EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release

Zhijia Wang iD, Samu V Himanen iD, Heidi M Haikala iD, Caroline C Friedel iD, Anniina Vihervaara iD, Matjaž Barborič iD

Nucleic Acids Research · 10.11.2023 · 51 (20) · 10970-10991

DOI: 10.1093/nar/gkad792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 09.10.2023. Verfasst von Zhijia Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki FIN-00014, Finland. Hauptthemen laut MEDLINE: Positive Transcriptional Elongation Factor B, RNA Polymerase II. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sigrid Juselius Foundation, Academy of Finland, Cancer Foundation Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-TEFb and CDK12 facilitate transcriptional elongation by RNA polymerase II. Given the prominence of both kinases in cancer, gaining a better understanding of their interplay could inform the design of novel anti-cancer strategies. While down-regulation of DNA repair genes in CDK12-targeted cancer cells is being explored therapeutically, little is known about mechanisms and significance of transcriptional induction upon inhibition of CDK12. We show that selective targeting of CDK12 in colon cancer-derived cells activates P-TEFb via its release from the inhibitory 7SK snRNP. In turn, P-TEFb stimulates Pol II pause release at thousands of genes, most of which become newly dependent on P-TEFb. Amongst the induced genes are those stimulated by hallmark pathways in cancer, including p53 and NF-κB. Consequently, CDK12-inhibited cancer cells exhibit hypersensitivity to inhibitors of P-TEFb. While blocking P-TEFb triggers their apoptosis in a p53-dependent manner, it impedes cell proliferation irrespective of p53 by preventing induction of genes downstream of the DNA damage-induced NF-κB signaling. In summary, stimulation of Pol II pause release at the signal-responsive genes underlies the functional dependence of CDK12-inhibited cancer cells on P-TEFb. Our study establishes the mechanistic underpinning for combinatorial targeting of CDK12 with either P-TEFb or the induced oncogenic pathways in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positive Transcriptional Elongation Factor BRNA Polymerase IINeoplasmsNF-kappa BRibonucleoproteins, Small NuclearRNA-Binding ProteinsTumor Suppressor Protein p53HumansCell Line, Tumor

Substanzen

NF-kappa BPositive Transcriptional Elongation Factor BRibonucleoproteins, Small NuclearRNA Polymerase IIRNA-Binding ProteinsTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki FIN-00014, Finland.
  • Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
  • Translational Immunology Research Program (TRIMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki FIN-00014, Finland.
  • iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki FIN-00014, Finland.
  • Institute of Informatics, Ludwig-Maximilians-Universität München, 80333 Munich, Germany.

ORCID-Profile: Zhijia Wang, Samu V Himanen, Heidi M Haikala, Caroline C Friedel, Anniina Vihervaara, Matjaž Barborič

Förderung

  • Sigrid Juselius Foundation
  • Academy of Finland
  • Cancer Foundation Finland
  • Deutsche Forschungsgemeinschaft
  • Swedish Research Council
  • Science for Life Laboratory
  • Helsinki University Library

Zitieren

APA

Wang, Z., Himanen, S. V., Haikala, H. M., Friedel, C. C., Vihervaara, A., & Barborič, M. (2023). Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release. Nucleic Acids Research, 51(20), 10970-10991. https://doi.org/10.1093/nar/gkad792

Vancouver

Wang Z, Himanen SV, Haikala HM, Friedel CC, Vihervaara A, Barborič M. Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release. Nucleic Acids Research. 2023;51(20):10970-10991. doi:10.1093/nar/gkad792

BibTeX
@article{Wang2023,
  author = {Wang, Zhijia and Himanen, Samu V and Haikala, Heidi M and Friedel, Caroline C and Vihervaara, Anniina and Barborič, Matjaž},
  title = {Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {20},
  pages = {10970--10991},
  doi = {10.1093/nar/gkad792}
}
Kostenlos starten →